user

Second-line chemotherapy in advanced biliary tract cancer: Who may benefit?

被引：2
|
作者：
Salati, Massimiliano
Caputo, Francesco
Marcheselli, Luigi
Rimini, Margherita
Spallanzani, Andrea
Gelsomino, Fabio
Andrikou, Kalliopi
Zironi, Sandra
Di Emidio, Katia
Clo', Vera
Luppi, Gabriele
Cascinu, Stefano
机构：
[1] Univ Hosp Modena, Dept Oncol & Hematol, Modena, Italy
[2] Univ Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, Modena, Italy
[3] Univ Hosp Modena, Modena, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.381
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
381
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Second-line chemotherapy in advanced biliary cancer: a systematic review
    Lamarca, A.
    Hubner, R. A.
    Ryder, W. David
    Valle, J. W.
    ANNALS OF ONCOLOGY, 2014, 25 (12) : 2328 - 2338
  • [22] Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: A large retrospective study
    Walter, Thomas
    Horgan, Anne M.
    McNamara, Mairead
    McKeever, Liz
    Min, Trisha
    Hedley, David
    Serra, Stefano
    Krzyzanowska, Monika K.
    Chen, Eric
    Mackay, Helen
    Feld, Ronald
    Moore, Malcolm
    Knox, Jennifer J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (02) : 329 - 335
  • [23] Prognostic Factors for the Selection of Patients Eligible for Second-Line Chemotherapy in Advanced Biliary Tract Cancer
    Kang, Eun Joo
    Choi, Yoon Ji
    Kim, Jung Sun
    Park, Kyong Hwa
    Oh, Sang Chul
    Seo, Jae Hong
    Kim, Hong Jun
    Kang, Ka-Won
    Yu, Eun Sang
    Shin, Sang W.
    Kim, Yeul H.
    Kim, Jun Suk
    CHEMOTHERAPY, 2014, 60 (02) : 91 - 98
  • [24] Second-line chemotherapy in biliary tract cancer: Outcome and prognostic factors
    Schweitzer, Nora
    Kirstein, Martha M.
    Kratzel, Anna-Maria
    Mederacke, Young-Seon
    Fischer, Mareike
    Manns, Michael P.
    Vogel, Arndt
    LIVER INTERNATIONAL, 2019, 39 (05) : 914 - 923
  • [25] Response to letter 'Outcome of second-line chemotherapy for biliary tract cancer'
    Walter, Thomas
    Horgan, Anne M.
    McNamara, Mairead
    McKeeve, Liz
    Min, Trisha
    Hedley, David
    Serra, Stefano
    Krzyzanowska, Monika K.
    Chen, Eric
    Mackay, Helen
    Feld, Ronald
    Moore, Malcolm
    Knox, Jennifer J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) : 1512 - 1513
  • [26] Second-line Treatment in Advanced Biliary Tract Cancer: Today and Tomorrow
    Rizzo, Alessandro
    Ricci, Angela Dalia
    Tober, Nastassja
    Nigro, Maria Concetta
    Mosca, Mirta
    Palloni, Andrea
    Abbati, Francesca
    Frega, Giorgio
    De Lorenzo, Stefania
    Tavolari, Simona
    Brandi, Giovanni
    ANTICANCER RESEARCH, 2020, 40 (06) : 3013 - 3030
  • [27] Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: A large retrospective study.
    Walter, Thomas
    Horgan, Anne
    McNamara, Mairead Geraldine
    McKeever, Elizabeth
    Min, Trisha
    Hedley, David W.
    Serra, Stefano
    Krzyzanowska, Monika K.
    Chen, Eric Xueyu
    Mackay, Helen
    Feld, Ronald
    Moore, Malcolm J.
    Knox, Jennifer J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] EFFICACY AND SAFETY OF S-1 AS SECOND-LINE CHEMOTHERAPY FOR PATIENTS WITH ADVANCED BILIARY TRACT CANCER
    Kobayashi, S.
    Ueno, M.
    Ohkawa, S.
    Andou, T.
    Kameda, R.
    ANNALS OF ONCOLOGY, 2012, 23 : 121 - 121
  • [29] Second-line therapies in advanced biliary tract cancers
    Tella, Sri Harsha
    Kommalapati, Anuhya
    Borad, Mitesh J.
    Mahipal, Amit
    LANCET ONCOLOGY, 2020, 21 (01): : E29 - E41
  • [30] Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy
    Fiteni, Frederic
    Jary, Marine
    Monnien, Franck
    Nguyen, Thierry
    Beohou, Eric
    Demarchi, Martin
    Dobi, Erion
    Fein, Francine
    Cleau, Denis
    Fratte, Serge
    Nerich, Virginie
    Bonnetain, Franck
    Pivot, Xavier
    Borg, Christophe
    Kim, Stefano
    BMC GASTROENTEROLOGY, 2014, 14
12345